ReviewCureus2026
Temporary Anchorage Devices and Clear Aligner Therapy: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear aligner therapy (CAT) has well-documented biomechanical limitations for demanding tooth movements, including molar distalization, posterior intrusion, and significant torque control. Temporary anchorage devices (TADs) provide a compliance-independent source of skeletal anchorage that may help overcome some of these limitations; however, the clinical evidence supporting their combined use with CAT remains incompletely characterized. This systematic review aimed to identify and critically appraise all available clinical evidence on the use of TADs in conjunction with CAT, synthesize findings according to clinical indication, evaluate methodological quality, and identify evidence gaps. Four electronic databases (PubMed, Cochrane Library, Web of Science, and Scopus) were searched from inception to April 2026, with an initial search conducted in May 2025 and an updated search performed in April 2026. Human clinical studies reporting orthodontic outcomes of combined TAD and CAT treatment were eligible for inclusion, while in vitro studies, reviews, and studies involving purely surgical applications of TADs were excluded. Study selection followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines. Methodological quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklists for case reports and case series and the Methodological Index for Nonrandomized Studies (MINORS) instrument for comparative and cohort studies. Fourteen studies published between 2009 and 2026, involving 109 patients, met the inclusion criteria, comprising five case reports, three case series, two prospective comparative studies, two retrospective comparative cohort studies, one retrospective observational cohort study, and one retrospective longitudinal study. No randomized controlled trials were identified. Clinical applications included maxillary molar distalization (six studies), mandibular molar distalization (three studies), vertical correction (two studies), transverse scissor-bite correction (one study), impacted canine management (two studies), and complex hybrid or surgery-first approaches (two studies). Across the available comparative studies, TAD anchorage was associated with reduced unwanted side effects, particularly anterior anchorage loss, molar tipping, and vertical adverse effects; however, distalization efficiency remained substantially below planned values, ranging from 32% to 71% in quantitative studies. Case reports and case series provided low-level evidence with substantial inherent bias, while comparative and cohort studies demonstrated moderate methodological limitations. Overall, the combination of TADs and CAT appears technically feasible and demonstrates proof of concept across a range of clinical applications, with the principal benefit being improved control of tooth movement rather than a proportional increase in the magnitude of achieved movement. Nevertheless, the overall certainty of evidence remains low, precluding definitive clinical recommendations. Well-designed randomized controlled trials incorporating standardized three-dimensional outcome measures are needed to establish the effectiveness of this treatment approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.